http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003532656-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
filingDate 2000-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003532656-A
titleOfInvention Compounds and methods for modulating amyloid vasculopathy in the brain
abstract (57) [Summary]nThe present invention provides a method for inhibiting amyloid vasculopathy in the brain. The present invention further provides a method of treating a pathological condition characterized by amyloid vasculopathy of the brain in a patient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010513219-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014103481-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010526046-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9745349-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4855268-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8513219-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007516940-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014141445-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013501733-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7212900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006059777-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535193-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018193999-A1
priorityDate 1999-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9815414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226516703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228058675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230590655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10219980

Total number of triples: 53.